[ad_1] CoronaVac, the coronavirus vaccine developed by China, is among the most advanced. Pending the first announcements on ongoing Phase III clinical trials, Phase I and II results have just been published in The Lancet. CoronaVac is based on a historical strategy: the live attenuated vaccine. China is also working …
Read More »Inserm takes stock of coronavirus reinfection
[ad_1] Reinfection with Sars-CoV-2, the source of the Covid-19 pandemic, is rare; however, according to the scientific community today, it does exist. Why do we get reinfected when others seem immune? Researchers are working to identify two sides of the same coin. Inserm and its Detox Channel take stock of …
Read More »